Kenvue Faces Challenges as Sales Fall Short of Expectations Amid Weak Volume for Tylenol

Kenvue, the consumer health division of Johnson & Johnson, has recently reported disappointing sales results that failed to meet Wall Street's projections. This trend has raised concerns among investors regarding the company's performance, particularly its flagship products like Tylenol, which are experiencing declining volumes in the market.

Continue reading